Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 1Other solid neoplasm 1Genitourinary 1Breast 1

Conditions

Mesothelioma, Malignant 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 6pembrolizumab 5fludarabine 4fludarabine phosphate 2amatuximab 2SS1(dsFv)PE38 2tocilizumab 1sotorasib 1sargramostim 1enzalutamide 1entinostat 1defactinib 1bemcentinib 1aldesleukin 1alanosine 1Tablets 1Sorafenib 1Sirolimus 1Quality of Life 1Polymerase Chain Reaction 1Pentostatin 1Pemetrexed 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Microarray Analysis 1Ipilimumab 1Interleukin-12 Subunit p35 1Interferon-gamma 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Interferon-alpha × Other solid neoplasm × Clear all
NCT00002475 2013-07-10

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡